Educational Qualifications of Dr. [Dr. Tejinder Kataria]:
Dr. Tejinder Kataria – A Pioneer in Radiation Oncology
With over 35 years of experience in radiation oncology, Dr. Tejinder Kataria is recognized as one of India’s foremost leaders in cancer care. Her groundbreaking contributions have set new benchmarks in medical technology and treatment precision, earning her global recognition.
Dr. Kataria made history by introducing India’s first Infinity Linear Accelerator with Volumetric Modulated Arc Therapy (VMAT) and establishing North India’s first Integrated Brachytherapy Unit. She also spearheaded the implementation of Stereotactic Body Radiotherapy (SBRT), offering precise and non-invasive treatment options for cancer patients.
Her leadership in oncology has led to the creation of premier Radiation Oncology Departments at prestigious institutions, including:
At Medanta – The Medicity, Dr. Kataria has integrated cutting-edge treatments, including:
Her approach focuses on precision, innovation, and patient-centered care, making Medanta a hub for advanced oncology.
Dr. Kataria’s academic background reflects her commitment to excellence. She has trained at renowned institutions, including:
A vital member of the QUATRO Asia team for the International Atomic Energy Agency (IAEA) since 2005, she has also contributed to the National Cancer Control Program under the Ministry of Health and Family Welfare during the 11th Five-Year Plan, playing a key role in shaping India’s oncology landscape.
Dr. Kataria’s expertise spans a wide range of advanced radiation oncology techniques:
Her unwavering dedication and contributions continue to revolutionize the field of radiation oncology in India and beyond, offering hope and exceptional care to patients worldwide.
Awards and Achievements of Dr. Tejinder Kataria
Pioneer in Radiation Oncology: Dr. Kataria introduced India’s first Infinity Linear Accelerator with Volumetric Modulated Arc Therapy (VMAT) and established North India’s first Integrated Brachytherapy Unit.
International Recognition: She has been a member of the QUATRO Asia team for the International Atomic Energy Agency (IAEA), Vienna, since 2005, contributing to the global development of radiation safety and treatment standards.
Leadership in Cancer Care: She played a pivotal role in setting up the Department of Radiation Oncology at esteemed institutions such as the Rajiv Gandhi Cancer Institute, Artemis Health Institute, and Medanta – The Medicity.
Contributions to National Health Programs: Dr. Kataria contributed to the Task Force Committee for the National Cancer Control Program under India’s Ministry of Health and Family Welfare during the 11th Five-Year Plan.
Academic Excellence: Her academic affiliations include reputed institutions such as PGI Chandigarh, University of Cambridge, University of Leeds, and Harvard University, reflecting her continuous commitment to excellence in oncology.
Mentor and Innovator: She has trained and mentored numerous upcoming oncologists and has spearheaded the integration of cutting-edge technologies, such as Stereotactic Radiosurgery (SRS) and Total Skin Electron Therapy (TSET), into cancer treatment protocols in India.
Professional Memberships of [Dr. Tejinder Kataria]:
Dr. Tejinder Kataria specializes in advanced radiation oncology techniques designed to deliver precise and effective cancer treatments while minimizing side effects. Her expertise includes Volumetric Modulated Arc Therapy (VMAT), which precisely targets tumors while protecting surrounding healthy tissue, making it ideal for treating complex cancers. She is also proficient in Image-Guided Radiotherapy (IGRT), which uses real-time imaging to enhance accuracy during treatment, and Intensity Modulated Radiotherapy (IMRT), a customized approach that adjusts radiation intensity to suit irregularly shaped tumors while safeguarding vital organs. Additionally, she excels in Stereotactic Body Radiotherapy (SBRT), a non-invasive, high-dose therapy that effectively treats small, localized tumors in fewer sessions, benefiting patients with cancers in areas like the lungs, liver, and spine.